【文獻標題】Serum proteomic predicts effectiveness ａnd reveals potential biomarkers for complications in liver transplant patients【作者】Wenjing Wang, Bo Wang, Chang Liu et.al
【作者單位】西安交通大學 （ Xi’an Jiaotong University）
【文獻中引用產品】
人ATP-檸檬酸裂解酶(ACLY)ELISA試劑盒
人纖維蛋白原α鏈(FGA)ELISA試劑盒
人載脂蛋白A1(ApoA1)ELISA試劑盒
【關鍵詞】 proteomic, serum biomarker, acute rejection (AR), ischemic-type biliary lesion (ITBL), liver transplantation
【DOI】https://doi.org/10.18632/aging.103381
【影響因子(IF)】4.6
【出版期刊】《AGING》
【產品原文引用】
All serum samples were analyzed blindly in triplicate ａnd the concentrations of ACLY (Shanghai Hengyuan, H-12925), FGA (Shanghai Hengyuan Biotech, H-12843) and APOA1 (Shanghai Hengyuan, H-11508) were measured according to the manufacturer’s instructions respectively.
完整版PDF文獻請咨詢在線客服或者電話聯系我司業務員！
更多公司福利請關注“恒遠生物”微信公眾號！
或訪問恒遠生物官網（http://www.hnybio.com）
原創作者：上海恒遠生物科技有限公司
總訪問量：7934131 
